NCT01484262View on ClinicalTrials.gov

Liraglutide or Insulin in Real Life Usage in Patients With Diabetes Mellitus Type 2

CompletedOBSERVATIONAL
Enrollment

1,344

Participants

Timeline

Start Date

November 14, 2011

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
DiabetesDiabetes Mellitus, Type 2
Interventions
DRUG

liraglutide

Patients will be treated according to routine clinical practice at the discretion of the treating physician according to current labelling.

DRUG

insulin

Any insulin in any device available on the market may be used by patients as part of routine clinical practice according to current labelling.

Trial Locations (1)

55127

Novo Nordisk Investigational Site, Mainz

Sponsors

Lead Sponsor

Novo Nordisk A/S
All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY